Results 71 to 80 of about 226,598 (287)

Multivariable regression model analyzing potential risk factors for post-COVID-19 syndrome. [PDF]

, 2022
Multivariable regression model analyzing potential risk factors for post-COVID-19 syndrome.
Maciej Debski (10589812), Samantha Weston (5927117), Eleana Ntatsaki (14197109), Shawn Haney (14197103), Vassilios S. Vassiliou (4246369), Aris Perperoglou (56097), Susan Madden (14197115), Katy Blakely (14197106), Vasiliki Tsampasian (14197100), Mark Lim (14197112)   +9 more
core   +1 more source

COVID-19 atypical Parsonage-Turner syndrome: a case report [PDF]

, 2022
BACKGROUND: Neurological manifestations of Sars-CoV-2 infection have been described since March 2020 and include both central and peripheral nervous system manifestations.
Landi F., Gremese E., Bizzarro A., Modoni A., Lauria A., Zazzara M. B.   +5 more
core   +1 more source

Peripapillary Retinal Vascular Involvement in Early Post-COVID-19 Patients [PDF]

, 2020
The ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ' s) to cause multi-organ ischemia and coronavirus-induced posterior segment eye diseases in mammals gave concern about potential sight-threatening ischemia in post coronavirus ...
Gemelli Against COVID-19 Post-Acute Care Study Group, Stanislao Rizzo, Savastano, Alfonso, Culiersi, Carola, Savastano, Maria Cristina, Gambini, Gloria, Grazia Cozzupoli, Emanuele Crincoli, Rizzo, Stanislao, Umberto De Vico, Maria Savastano, Alfonso Savastano, Crincoli, Emanuele, Gloria Gambini, Saad Younis, Carola Culiersi   +15 more
core   +1 more source

Efficacy of Therapeutic Exercise in Reversing Decreased Strength, Impaired Respiratory Function, Decreased Physical Fitness, and Decreased Quality of Life Caused by the Post-COVID-19 Syndrome

Viruses, 2022
In the current global scenario, many COVID-19 survivors present a severe deterioration in physical strength, respiratory function, and quality of life due to persistent symptoms and post-acute consequences of SARS-CoV-2 infection.
Diego Fernández-Lázaro, Gema Santamaría, Nerea Sánchez-Serrano, Eva Lantarón Caeiro, Jesús Seco-Calvo   +4 more
doaj   +1 more source

Post-COVID-19 syndrome in a cohort of hospitalized COVID-19 patients.

European review for medical and pharmacological sciences, 2023
The study aimed to investigate the frequency of post-COVID-19 syndrome and associated factors in patients who visited the post-COVID-19 outpatient clinic after hospital discharge in the first, third, and sixth months of the first year of the pandemic.The study was a clinical cohort study of patients hospitalized due to COVID-19.
Bildirici, Y., Metintas, S., Ucan, A., Ak, G., Eker Guvenc, S., Metintas, M.   +5 more
openaire   +2 more sources

The co-administration of intranasal insulin and GLP-1RA as targeting drugs for prophylaxis and treatment of post COVID-19 smell and taste dysfunctions and brain fog

Advances in Biomedical and Health Sciences, 2023
The coronavirus disease (COVID-19) pandemic has resulted in high infection rates, significant morbidity, and postmortality among older adults, resulting in a global burden of COVID-19 survivors' long-term care.
Amr Ahmed, Aml M Barakat
doaj   +1 more source

Delivery of DNA‐encoded vaccines and proteins in mice using cutaneous suction‐mediated transfection

FEBS Open Bio, EarlyView.
Cutaneous suction‐mediated transfection in mice for delivery of DNA‐encoded vaccines and proteins. A critical limitation of DNA vaccines and other therapeutics is transfection in vivo to produce the encoded antigens or therapeutic proteins. Cutaneous suction‐based methods have demonstrated effectiveness in many animal models and have been successfully ...
Emran O. Lallow, Isabel Brandtjen, Yaxin Mo, Melissa Gulley, Louis Osorio, Sagar Kudchodkar, Nandita C. Jhumur, Christine C. Roberts, Lisa K. Denzin, David I. Shreiber, Biju Parekkadan, Hao Lin, Joel N. Maslow   +12 more
wiley   +1 more source

Identification of (20R)‐protopanaxadiol from Panax ginseng as a novel anti‐SARS‐CoV‐2 compound

FEBS Open Bio, EarlyView.
We established a noninfectious BAC‐based SARS‐CoV‐2 replicon that enables antiviral screening under BSL‐2 conditions. Using this platform, we screened 373 food‐derived compounds and identified (20R)‐protopanaxadiol from Panax ginseng as a novel inhibitor of SARS‐CoV‐2 RNA replication, highlighting the value of safe replicon systems for antiviral ...
Midori Takeda, Natsue Maezono, Rina Uchikoshi, Nobuyuki Kato, Masanori Ikeda   +4 more
wiley   +1 more source

Case Report: a Guillain Barré Syndrome post COVID-19 [PDF]

, 2020
We describe a typical case of COVID-19 interstitial lung damage, with a favourable evolution, which was followed by a typical Guillain Barré ...
Cortassa Giorgio Mario, Bottone Stefania, Nebiolo Mario   +2 more
core   +1 more source

Influenza Vaccination Responses in Disabled Stroke Patients: A Single‐Center Prospective Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao, Sureerat Suwatcharangoon, Pintip Ngamjanyapron, Kobporn Boonnak, Thanitta Suangtamai, Porpon Rotjanapan   +5 more
wiley   +1 more source